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Abstract
The present report is a part of our continuing efforts to explore the utility of the rat epidermal keratinocyte organotypic culture (ROC) as an
alternative model to human skin in transdermal drug delivery and skin irritation studies of new chemical entities and formulations. The aim of the
present studywas to compare the stratum corneum lipid content of ROCwith the correspondingmaterial from human skin. The lipid composition was
determined by thin-layer chromatography (TLC) and mass-spectrometry, and the thermal phase transitions of stratum corneum were studied by
differential scanning calorimetry (DSC). All major lipid classes of the stratum corneum were present in ROC in a similar ratio as found in human
stratum corneum. Compared to human skin, the level of non-hydroxyacid-sphingosine ceramide (NS) was increased in ROC, while α-hydroxyacid-
phytosphingosine ceramide (AP) and non-hydroxyacid-phytosphingosine ceramides (NP) were absent. Also some alterations in fatty acid profiles of
ROC ceramides were noted, e.g., esterified ω-hydroxyacid-sphingosine contained increased levels of oleic acid instead of linoleic acid. The fraction
of lipids covalently bound to corneocyte proteins was distinctly lower in ROC compared to human skin, in agreement with the results from DSC.
ROC underwent a lipid lamellar order to disorder transition (T2) at a slightly lower temperature (68 °C) than human skin (74 °C). These differences in
stratum corneum lipid composition and the thermal phase transitions may explain the minor differences previously observed in drug permeation
between ROC and human skin.
© 2008 Elsevier B.V. All rights reserved.Keywords: ROC; Reconstructed epidermis; Stratum corneum; Lipid composition; DSC; TLCAbbreviations: AS, α-hydroxyacid-sphingosines; AP, α-hydroxyacid-phyto-
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gosines; NH, non-hydroxyacid-6-OH-sphingosines; REK, rat epidermal keratino-
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The uppermost layer of the skin, i.e. stratum corneum, is
known to provide a barrier against water loss and to prevent the
intrusion of microorganisms and chemicals. Epidermal keratino-
cyte proliferation, differentiation and cell death occur sequen-
tially, and the stratum corneum represents the final stage of the
differentiation process. Dead corneocytes are filled with keratin
filaments and enclosed in highly organized lipid lamellae [1].
During differentiation, the epidermal lipid content and com-
position change dramatically in the interface of stratumgranulosum
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cholesterol and glucosylceramides) are enclosed into vesicles,
lamellar bodies, in the granular cells [2,3]. After the extrusion of
lamellar bodies at the interface of stratum granulosum and stratum
corneum, polar lipids are enzymatically converted intomore apolar
products; phosphoglycerides to free fatty acids, and sphingomyelin
and glucosylceramides to ceramides [4]. These lipids and
cholesterol then form the lipid lamellae with their characteristic
orthorhombic lateral organization and repeating pattern of 6 nm
(short periodicity phase, SPP) and 13 nm (long periodicity phase,
LPP) [5,6]. The stratum corneum contains an approximately
equimolar ratio of cholesterol, ceramides and free fatty acids,
which is important for the orthorhombic packing and formation
of LPP [7]. The presence of ω-hydroxyceramides, especially
esterified ω-hydroxysphingosine (EOS), is critical for the proper
molecular organization of LPP structures, although the pres-
ence of all nine ceramide subclasses further supports LPP
formation [8–10].
The protein rich cornified envelope finally replaces the plas-
ma membrane of differentiated cells, and approximately two-
thirds of the total ω-hydroxyceramides are covalently bound to
the outer surface of envelope proteins where they form lipid–
protein complexes [11–13]. These structures contain one layer
of lipids bound via ester bonds to glutamic acid residues of
cornified envelope protein, mainly involucrine [14]. Covalently
bound ceramides are believed to serve as a template for the
formation of lipid lamellae in the extracellular space. Although
an elevated transepidermal water loss has been attributed to a
decline in the number of covalently bound ceramides [15], the
relationship between bound lipid and the barrier function of the
stratum corneum is not well established.
There are several reasons why reconstructed skin models are
predicted to replace the native skin in in vitro experiments; there
are fewer ethical concerns, they are easy to prepare and provide
more reproducible results. However, such models need to be
morphologically and physiologically equivalent to human skin.
To produce these models, keratinocytes can be seeded onto
synthetic matrices, collagenated matrices, fibroblast containing
collagen matrices or cultured on de-epidermised dermis, and are
grown in an airlifted state [16–26]. Often the general ultra-
structure of the model epidermis is similar to that of native skin.
In the most advanced skin models, the overall lipid composition
of the epidermis approaches that of native skin, but the orga-
nization of the lipid lamellae may be altered [27,28]. Also the
differentiation process in many models is disturbed, as indicated
by retarded lamellar body extrusion, the absence of LPP and
covalently bound ceramides, the presence of intercellular lipid
droplets and crystalline cholesterol as well as over- or under-
expression of key proteins and enzymes [28]. This might lead
to differences in the molecular composition of the individual
lipid classes, which can disturb normal lipid packaging. One
such difference is the substitution of linoleate for oleate in
EOS [19,29]. Although the lipid composition and arrangement
in skin models can be improved by modifying the culture
conditions [30,31], many reports have revealed that these skin
models are still significantly more permeable than human skin
[18,32–35].The rat epidermal keratinocyte organotypic culture (ROC) is
a three-dimensional skin model that exhibits a normal stratum
corneum ultrastructure and functional properties [26,36]. It has
been shown to (i) form a drug permeability barrier very similar to
that of human skin [37], (ii) correctly predict the skin irritation
potential of topically applied chemicals [38], (iii) respond to
dermal penetration enhancers in the same way as human skin
[39], (iv) be useful as a tool for dermal gene delivery studies [40]
and (v) mimic skin in iontophoretic studies (Raiman, J. et al.,
University of Helsinki, Division of Pharmaceutical Technology,
unpublished data). The main advantage of ROC in pharmaceu-
tical and chemical testing is its well developed permeability
barrier which is often lacking in several of the cultured skin
models. The lipid matrix of stratum corneum is considered to
constitute the major barrier to percutaneous penetration. ROC
has previously been demonstrated to contain lamellar bodies,
which are completely extruded into the stratum granulosum/
stratum corneum interface [26,36]. Most of the intercellular
lipids form a typical repeating pattern of Landmann units [2],
although there may be some abnormal lipid droplets, an anomaly
not untypical for reconstructed skin models. ROC also contains
the cornified envelopes and its components, such as keratin
filaments, involucrine and filaggrin.
We are continuing to explore the utility of the rat epidermal
keratinocyte organotypic culture (ROC) as an alternative model
to human skin in transdermal drug delivery and skin irritation
studies. ROC is still slightly leakier than human skin [37] and in
this study we have evaluated whether this could be explained by
the deviations in the lipid profiles of the stratum corneum of
these two models. Therefore we compared the lipid composition
of ROC and human stratum corneum in detail using thin-layer
chromatography (TLC) and mass-spectrometry. In addition, the
thermal behavior of ROC and human stratum corneum was
investigated by differential scanning calorimetry (DSC). The
results show that all of the major lipid classes typical for native
skin were present in ROC in a comparable ratio as found in
human stratum corneum. However, the differences in the DSC
profiles indicate that the stratum corneum of human skin and
ROC do differ in their structural characteristics.
2. Materials and methods
2.1. Materials
Minimal Essential Medium (MEM; without L-glutamine), Dulbecco's MEM
(DMEM;with 4500mg/l glucose), Earle's Balanced Salt Solution (EBSS, 10x) and
7.5% sodium bicarbonate solution were obtained from Gibco BRL (Life Techno-
logies Ltd., Paisley, Scotland). PBS tablets for preparation of pH7.4 buffer solution,
penicillin–streptomycin sulfate solution, L-glutamine solution, trypsin–EDTA
solution, L-ascorbic acid, trypsin type III from bovine pancreas, trypsin inhibitor
type II from soybean, cholesterol, cholesterol sulfate, copper sulfate and sodium
bromide were purchased from Sigma (St. Louis, MO, USA). Fetal bovine serum
(FBS) was from HyClone (Logan, UT, USA). Transwell tissue culture inserts
(24 mm diameter, 3.0 μm pore size) were obtained from Costar (Cambridge, MA,
USA). CeramideNS and glucosylceramidewere obtained fromAvanti Polar Lipids
(Alabaster, Alabama, USA), and C24:0 fatty acid, acetic acid and ortho-phosphoric
acid from Fluka (Buchs, Germany). n-Hexane and chloroformwere fromRathburn
Chemicals (Walkerburn, Scotland), methanol from LabScan (Dublin, Ireland) and
diethylether from Baker (Deventer, Holland). Sodium hydroxide was fromOY FF-
Chemicals AS (Yli-Ii, Finland) and NaBr from Sigma-Aldrich (Seelze, Germany).
Fig. 1. TLC analysis of stratum corneum lipid composition: A representative
sample for free lipids (200 μg) (I) and covalently bound ω-hydroxyceramides
(II, line 6) (in similar volume to free lipids) extracts of ROC and human stratum
corneum (HS) is shown. CER: ceramide; CHOL: cholesterol; CS: cholesterol
sulfate; CE: cholesterol esters, FFA: free fatty acids, GlcCER: glucosylcer-
amides, TG: triglycerides.
Fig. 2. Lipid composition (mean wt. %±S.D.) of stratum corneum free lipid
extracts of ROC (white bars) and human skin (black bars) as determined by TLC
analysis. Lipid amount: Percent of total lipid in the respective lipid class. FFA: free
fatty acids, CER: ceramides; CHOL: cholesterol; CS: cholesterol sulfate (n=4–5).
826 S. Pappinen et al. / Biochimica et Biophysica Acta 1778 (2008) 824–8342.2. REK organotypic culture (ROC)
Rat epidermal keratinocyte (REK) cell line from newborn rats, which was
originally isolated as previously reported [41], was used. Stock cultures were
grown in MEM supplemented with 10% FBS, 4 mM L-glutamine, 50 U/ml
penicillin and 50 μg/ml streptomycin sulfate at 37 °C and in 5%CO2, according to
the protocol described earlier [26,36]. For the organotypic cultures (ROC), REKs
were seeded onto collagen coated Transwell culture inserts (400,000 cells/insert)
using DMEM supplemented with 10% FBS, 4 mM L-glutamine, 50 U/ml
penicillin, 50 μg/ml streptomycin sulfate and 40 μg/ml L-ascorbic acid at 37 °C
and in 5% CO2 as described earlier [26,36]. The cultures were grown airlifted for
three weeks prior to use. The barrier integrity was monitored periodically by
examining the permeation of a lipophilic compound, corticosterone, and a hydro-
philic compound, mannitol, to ensure the uniformity of culture batches [37].
2.3. Isolation of stratum corneum from human skin and ROC culture
Excised human abdomen skin samples were obtained from the Kuopio
University Hospital (Kuopio, Finland), within four days post-mortem. The
contact of subcutaneous tissue with the stratum corneum was prevented in each
step of sample preparation to avoid contamination with dermal lipids. The fat
tissue was removed and the skin samples were rinsed with ice-cold hexane for
30 s to remove unwanted surface lipids [42]. The dermal side of the skin tissue
was placed into contact with a 0.1% trypsin solution in PBS at 37 °C for 2–3 days
and the trypsin solution was replaced by fresh solution every 24 h until the
stratum corneum could be peeled off. The treatment with ice-cold hexane for 30 s
was repeated and the stratum corneumwas rinsed with purified water. To achieve
the optimal removal of all epidermal cells, the stratum corneum sheets were
treated once more with 0.1% trypsin in PBS for 2 h at 37 °C. Then the stratum
corneum was peeled off and placed into a 0.1% trypsin inhibitor solution inpurified water and finally rinsed with purified water. Separated stratum corneum
sheets were briefly air dried and placed in a desiccator over a silica gel, under
nitrogen and light protection for later use.
ROC epidermal membrane was peeled off from the culture insert and
collagen support, rinsed for 30 s with ice-cold hexane in the same way as human
stratum corneum and placed in 0.1% trypsin solution in PBS for 2 h at 37 °C.
Thereafter, the stratum corneum was peeled off, treated with 0.1% trypsin
inhibitor solution, rinsed with purified water and stored in the same way as
human skin after drying at room temperature.
2.4. Extraction of lipids
About 40mg of the dry stratum corneumwas cut into small pieces and placed
in a silanized Pyrex tubes (Barloworld Scientific, Staffordshire, UK). Free lipids
were extracted using first three consequent extractionswith chloroform/methanol
in different ratios (2:1, 1:1, 1:2 v/v) as described previously [43], and finally with
a single two-hour extraction with methanol. Thereafter, the remaining material
was subjected to a mild alkaline hydrolysis to extract the lipids covalently bound
to proteins [12]. The extract of covalently bound lipids and the combined extracts
of free lipids were evaporated under nitrogen flow at room temperature, dissolved
in 5 ml of chloroform/methanol (2:1 v/v) and washed with 1 ml of 0.88% KCl in
water (w/v) [44]. After evaporation of the solvents under nitrogen flow, the lipids
were dissolved in chloroform/methanol (2:1 v/v) at a concentration of 10 mg/ml
and stored at −20 °C.
2.5. TLC analysis of lipid classes
The lipids were analyzed by a thin-layer chromatography using 20×20 cm
glass plates coated with a 0.25 mm thick silica gel layer (Merck, Darmstadt,
Germany). Samples of 5, 10, 15 and 20 μl of the free lipid extract and 20 µl of
covalently bound lipid extract were applied to the plate. The lipids were separated
by one-dimensional TLC using the following solvent systems sequentially:
chloroform/methanol/water 40:10:1 (v/v/v) to 10 cm; chloroform/methanol/acetic
acid 190:9:1 (v/v/v) to 16 cm; hexane/diethylether/acetic acid 70:30:1 (v/v/v) to
20 cm [45]. Before developing the plates with a new mobile phase, the plates were
carefully dried under a gentle air stream. Lipid classes were identified by com-
paring the lipid spots of the stratum corneum samples with cholesterol, free fatty
acid (C24:0), ceramide NS (C24:0), glucosylceramide and cholesterol sulfate
standards. After development and drying, the plates were dipped into CuSO4⁎7
H2O (7.5%w/v)/phosphoric acid (8% v/v) solution and heated at 180 °C for 8 min.
The plates were then laser-scanned and the integrated density of standard and
sample lipid bands was quantified by Dot plot analysis of the ImageJ software
(Wayne Rasband, National Institute of Health, USA). Results were calculated from
standard curves.
Table 1
Composition of ceramide spots separated from TLC plate and analyzed by mass-
spectrometry
Ceramide spot Human stratum corneum ROC
1 EOS EOS
2a NS NSC22–31
2b EOP NSC16–20
3 NP,EOH EOH,NHC28–30
4 AS,NH AS,NH
5a AP,AH AH
5b – AHC16–24
6 OS,OH,OP OS,OH,OP
EO = esterified ω-hydroxyacid, N = non-hydroxyacid, A = α-hydroxyacid,
S = sphingosine, P = phytosphingosine, H = 6-hydroxysphingosine.
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Free and covalently bound ceramide classes separated by TLC were scraped
from the plate and extracted for 5 min with ultrasonication in 3 ml of chloroform/
methanol (1:1 v/v) in silanized Pyrex tubes. The extracts were first washed with
0.75 ml of purified water and then with 1 ml of chloroform/methanol/water 2:2:1
(v/v/v) upper phase [44]. The organic solvents were evaporated and the residues
were dissolved in chloroform/methanol (1:2 v/v) prior to analysis. Identification
of the classes and molecular species was carried out by LC-ESI-MS/MS.
Chromatographic separation was carried out in the gradient mode using a Famos
autosampler and Ultimate nano-HPLC apparatus (LC Packings, Amsterdam,
Netherlands) equipped with a 2.1×50 mm Discovery C18 column (Supelco,
Bellefonte, PA) packed with 5 μm particles. The solvents used were A =
methanol/water/formic acid (74:25:1, v/v/v), B =methanol/formic acid (99:1 v/v)
and C = chloroform/methanol/formic acid (33:66:1 v/v/v), each containing 5mM
ammonium formate. The gradient started from 100%A and was changed linearly
to 100% B at 20 min, and after 10 min changed linearly to 100% C within 5 min.
After 5 min, the solvent was changed linearly to 100% B in 5 min and then to
100% A in 5 min. The column was equilibrated for 10 min with 100% A prior to
the next injection. The flow rate was 0.5 ml/min.
The column eluent was introduced into the electrospray source of a Quattro
Micro triple-quadrupole mass-spectrometer (Micromass, Manchester, UK)
operated in the positive ion mode. Nitrogen was used as the nebulizer (500 l/h
at 130 °C) and cone gas (50 l/h). The source temperature was 90 °C and theFig. 3. Relative proportions (wt. %) of different free and covalently bound (OS,OP,
determined by TLC analysis (n=4–5).potentials of the cone, extractor and RF lens were 40, 2 and 0.3 V, respectively.
The precursor ion spectra were scanned from 500 to 1200 m/z at a frequency of
one scan per two seconds. The ceramides were identified according to their
molecular weight, characteristic fragmentation pattern [46] and elution time.
After identification, the molecular species of each ceramide subclass were ana-
lyzed semi-quantitatively using direct infusion of the crude lipid extract and
scanning for the precursors of the different sphingoid bases [46]. The spectra
were smoothed, transferred to Microsoft Excel and the relevant peaks were
quantified using the LIMSA-software recently designed for this purpose [47].
Analysis of the phospholipid classes and molecular species was carried out
essentially as described previously [48]. Briefly, the different phospholipid
classes were selectively detected by using head group-specific precursor ion or
neutral loss scanning modes and quantified using internal standards. Phospha-
tidylcholines and sphingomyelins were detected by scanning for the precursors of
184 and phosphatidylethanolamines by scanning for constant neutral loss 141 in
the positive ion mode. The collision energy was set to 20–55 eVand argon was
used as the collision gas. The spectra were then analyzed as described above.
2.7. Differential scanning calorimetry
Dry stratum corneum sheets were hydrated over a 27% NaBr solution for 48 h
to ensure 20%hydration [49]. Phase transition temperatures of the stratumcorneum
are known to be stable in awater content of 20%orgreater [50]. The sheetswere cut
into small pieces and 3–4mgwere hermetically sealed in 10μl aluminiumpans and
analyzed using a DSC 823e instrument (Mettler Toledo, Schwerzenbach,
Switzerland). An empty pan was used as reference. The calorimeter was calibrated
using zinc, lead, indium and milli-Q water under nitrogen plugging gas flow of
50 ml/min. The samples were heated from 10 to 110 °C, cooled to 0 °C and heated
up again with a scan rate of 10 °C/min. Isothermic steps with a duration of 2 min
were inserted between all temperature scans. TheDSC curves are normalized to the
sample mass (hydrated stratum corneum) and the transition temperatures are
referred to the peak maxima determined in the heating runs.
3. Results
3.1. Stratum corneum lipid composition
Stratumcorneumof human skin andROCcontained 15.1±0.4%
(151 μg/mg) and 12.9±1.2% (129 μg/mg) of lipids of the dryOH) ceramide subclasses in stratum corneum of ROC and human skin (HS) as
Fig. 4. Molecular species composition of ceramide subclasses. Total lipid extract analysis of ROC (white bars) and human skin (black bars) by mass-spectrometry. Relative abundance: Percent of acyl chain lengths in the
respective ceramide class.
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Fig. 5. Representative DSC heating curves of human (a) and ROC (b) stratum
corneum. The average transition temperatures and standard deviations are 33.4±1.7;
49.5±2.1; 73.6±1.3; 86.1±1.5 °C for human and47.2±2.0; 67.5±0.4; 89.0±0.7 °C
for ROC stratum corneum, respectively (n=4).
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um from human skin and ROC samples displayed very similar lipid
compositions (Fig. 1). The proportions of the three main lipid
classes, i.e., ceramides, cholesterol and fatty acidswere very similar,
albeit the proportion of free fatty acid was slightly reduced in ROC
stratum corneum (10% less than in human stratum corneum)
(Fig. 2). The level of cholesterol sulfate was significantly higher in
ROC stratum corneum (40%more than in human stratum corneum)
(Fig. 2). Stratum corneum of both human skin and ROC contained
only low amounts of phospholipids, 0.4% and 0.2% of total lipids,
respectively. However, in human skin half of the phospholipids
were phosphatidylethanolamines, andROC containedmainly phos-
phatidylcholine and its alkyl derivatives. There were only trace
amounts of glucosylceramides in both samples.
3.2. Ceramide subclass compositions
Mass-spectrometric analysis of the ceramide bands separated
by TLC revealed differences in the ceramide subclass composi-
tions of ROC and human skin extracts (Table 1). In ROC, the
EOP, NP and AP subclasses were not detectable and band 4
consisted mainly of AS and band 5 (a+b) only of AH, while in
human skin, band 4 consisted equally of AS and NH and band 5a
equally of AP and AH. TLC quantification of the subclasses
revealed that although the total amounts of ceramides in native
skin and ROC were similar, the proportions of ceramide sub-classes differed clearly (Fig. 3). Ceramides EOP, NP and AP
were undetectable in ROC, and it contained more ceramide NS
than human skin. Also the content of free EOS was higher in
ROC, while the content of ceramides covalently bound to pro-
teins (OS, OH, OP) was significantly lower in ROC, only 1/3 of
that in human skin.
Mass-spectrometric analyses indicated that the fatty acid
profiles of ceramides NS, AS, NH and AH were generally sim-
ilar in ROC and human skin, although some differences in rela-
tive abundances were observed (Fig. 4). NS ceramide of human
skin contained equal amounts of acyl chains C16:0, C24:0 and
C26:0, while C24:0 dominated in ROC. In ceramide AS from
human skin, the acyl chain length varied from 16 to 30 carbons,
while AS from ROC contained mainly C30:0 and C32:0 fatty
acids. In NH from human skin, C24:0, C26:0 and C28:0 domi-
nated, while in ROC the average acyl chain length was signif-
icantly smaller. In ceramide AH of ROC, acyl chains C16:0–
C32:0 were observed, while human skin containedmainly C24:0
and C26:0 chains.
Mass-spectrometric analysis of the total lipid extract indi-
cated the presence EOP in ROC, although this subclass was not
apparent in the TLC analysis. Themajor amide-linked fatty acids
of EOP and EOH in both ROC and human stratum corneumwere
C28:0 and C30:0, respectively, and in both cases the ω-ester-
linked chain was linoleic acid (C18:2) (Fig. 4). However, in
EOH there were also trace amounts of ω-ester-linked oleic acid
in human skin (0.7%) and ROC (7.5%). In EOS, the main amide-
linked fatty acid was C30:0 and contained both ester-linked
linoleic and oleic acids, but the proportion of linoleic acid was
lower in ROC (42%) compared to that found in human skin
(64%).
3.3. Differential scanning calorimetry
Four phase transitions (average at 33, 50, 74 and 86 °C) were
observed in stratum corneum of human skin and three (average at
47, 68 and 89 °C) in ROC when samples of four different donors
and culture batches were analyzed (Fig. 5). The first minor
transition (T1) occurred at 33 °C in native skin, but was absent in
ROC. The second small transition (Tx) was observed around
50 °C in both membranes. The main lipid-associated phase
transition in human skin occurred at 74 °C (T2), but at 68 °C in
ROC. The high temperature transition (T3) had a much lower
enthalpy in ROC and occurred at a higher temperature (89 °C)
than in human skin (86 °C). On reheating, the two lipid tran-
sitions T2 and T3 coalesced into a single endotherm (detectable as
themain peak and the shoulder) at approximately 67 and 72 °C in
human skin and ROC, respectively. The T1 and Tx transitions
were not reversible under these conditions.
4. Discussion
Although the lipid composition of skin model cultures has
been investigated, these studies have mainly focused on the
lipids present in the entire epidermis rather than stratum corne-
um [18,28,51]. However, the lipid composition changes dra-
matically from stratum granulosum to stratum corneum. In skin
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half of that in human skin, while stratum corneum is about twice
as thick, in some cases even 10-fold thicker than in human skin
[27,28]. These variations complicate comparisons between mo-
dels as well as with human skin. This problem can be avoided by
analyzing isolated stratum corneum as was done here.
ROC stratum corneum contained cholesterol, ceramides and
FFA in almost the same proportions as found in the skin (28 vs
27% cholesterol, 52 vs 51% ceramides, 17 vs 21% FFA for the
ROC and human stratum corneum, respectively) (Fig. 2). The
epidermal phospholipids were efficiently degraded to free fatty
acids and thus mature stratum corneum of ROC, like that of
human skin, was found to contain only minute quantities of
phospholipids. The lipid composition of the stratum corneum of
other reconstructed skin models differs more extensively from
human skin (Table 2). For example, the human keratinocyte
culture LSE has been reported to contain a higher amount of
cholesterol (∼66%) and much less ceramides (∼27%) and FFA
(∼7%) compared to human stratum corneum [52].
Lipids in human skin form highly ordered lamellar struc-
tures, characterized by a long periodicity phase (LPP) of approx.
13 nm (Table 2) [6]. It is known that cholesterol, free fatty acids
and ceramides, especially EOS, are essential components of this
structure [10,53]. In human skin, the ω-linked acyl chain in
hydroxyceramides is typically linoleic acid (C18:2) which must
be obtained from the diet. In essential fatty acid deficiency,
linoleate is partially replaced by oleate and this results in skin
hyperproliferation and an altered barrier function [54,55]. In the
present study, the EOS content of ROC was similar, or slightlyTable 2
Stratum corneum structure analysis of human skin and epidermal skin models
Source Lipid content of model
SC in comparison to
human SC
Ceramide subclasses
Human CERs (18–41%)
CHOL (14–33%)
FFAs (9–20%)
CS (2–6%)2
Nine classes3
ROC4 Equal amount of CHOL
and CERs, slightly less
FFAs, more CS
More NS, absence of
NP and AP
EpiDerm6 – More NS, less AS and
AP, absence of AH
Episkin – More NS, less AS and
AP, absence of AH6
SkinEthic,
CSS10
– More NS, less AS and
AP, absence of AH
RE-DED Equal amount of CHOL and
CERs, much less FFAs11
Almost equal to
human skin6
LSE More CHOL, much less
CERs and FFAs,
equal amount of CS13
More NS, less AS and
AP, absence of AH14
In-house
model15
More CHOL, much less
CERs and FFAs
–
In-house
model16
More CHOL, much less
CERs and FFAs
Reduced amount of
most polar ceramides
Data shown is summary of literature reports and the present study. LP=lamellar phase
5[12], 6[28], 7[68,77–79], 8[79], 9[27], 10[28,31], 11[80], 12[63], 13[52], 14[31], 15[61]higher, to that of the native skin (Fig. 3). The linoleic acid was
the only ω-linked acyl moiety in EOH and EOP both in ROC
and human skin, while in EOS of ROC linoleic acid represented
42% of total ω-linked chains (Fig. 4). It is still somewhat less
than the level present in human skin (64%). In the other skin
models which have been investigated (EpiDerm penetration
model, EpiDerm irritation model, Episkin penetration model,
Episkin irritation model, SkinEthic, RE-DED) the proportion of
EOS of total ceramides (8–15%) was reported to be similar to
that in human skin (∼9%), but LPP (∼12 nm) has been found in
only a few samples (EpiDerm penetration model, RE-DED)
[28]. In skin models, the ω-linked linoleic acid is largely re-
placed by oleic acid [19,29,56]. Calf serum in the culture me-
dium is the only source of essential fatty acids for the cells, but
this contains only low amounts of linoleic acid (18:2) and
linolenic acid (18:3) [57,58]. Addition of a mixture of fatty
acids (palmitic, linoleic and arachidonic acids) to a serum free
culture medium has been reported to improve this situation, but
nonetheless only 10–20% of ω-linked acyl chains in hydro-
xyceramides were in the linoleate form (compared to 70–80%
in human skin) [29] (Table 2).
The proportion of ceramide NS in ROC was higher than in
native stratum corneum and ceramides NP and AP were not
detected (Fig. 3). Ponec and coworkers have analyzed the cera-
mide profile of a reconstructed human keratinocyte culture (RE-
DED) [19,31]. They found higher proportion of NS, lower
proportions of AS andAP than in human skin, and the absence of
AH, when the cultures were grown inmediumwithout serum but
with fatty acid supplementation (i.e. palmitate, linoleinate andLinoleate
content of
EOS (%)
Covalently
bound
ceramides
LPP
(nm)
Thermal phase
transitions
(DSC) (°C)1
70–802
644
1.4% of the
dry mass
6.4
13.46
36–407, 334 (T1)
518, 504 (Tx)
65–757, 744 (T2)
78–857, 864 (T3)
42 Present, 1/3 of
that in human
skin
– 47 (Tx), 68 (T2),
89 (T3)
– – 12 –
– – nd9 –
– – – –
10–203 Present, equal
amount to
human skin12
126 –
– – – –
– Absent – –
– Absent – 58 (T2)
s, nd = not detected, 1hydration level about 20%, 2[74–76], 3[29], 4present study,
, 16[62].
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commercial skin models (EpiDerm, SkinEthic, Episkin and
LSE) and for an in-house model (cultured skin substitute, CSS)
[27,28,31] (Table 2). However, the supplementation of RE-DED
medium with vitamin C led to a ceramide profile similar to that
of native epidermis [29,31,59]. We have routinely included
vitamin C in the culture medium, but these deviations in cera-
mide composition of ROC might be alleviated by inclusion of
suitable fatty acids in the medium.
Morphological studies have reported that ROC contains
cornified envelopes in the stratum corneum and these are re-
sponsible for the characteristic components of the envelope such
as keratin filaments, involucrine and filaggrin [26,36]. We found
covalently bound ceramides in stratum corneum of ROC, albeit
in lesser amounts (1/3) than in human skin (Fig. 3). On the other
hand, ROC seem to contain free ω-hydroxyceramides, even in
higher amounts than are present in skin. The lack of some
proteins or enzymes essential for keratinocyte differentiation, or
the lack of essential fatty acids, respectively, might be re-
sponsible for the lower amount of covalently bound ceramides in
ROC [15,60]. The presence of covalently bound ceramides in
reconstructed skin models has not been widely studied (Table 2).
While Kennedy et al. [61] and Pouliot et al. [62] did not find any
covalently bound ceramides in their reconstructed human epi-
dermis, Ponec et al. [63] did detect these compounds in amounts
comparable with those in native skin.
We observed four endothermic transitions related to lipids in
human stratum corneum, i.e. at 33, 50, 74 and 86 °C and three
phase transitions in ROC, i.e. at 47, 68 and 89 °C (Fig. 5). The
average thermal phase transitions of human stratum corneum
from four different donors deviated somewhat from data pub-
lished on samples with a similar level of hydration (about 20%;
Table 2), though the reasons for this are not obvious. Since we
were only interested in lipid-associated transitions, the scans
were not extended to the high temperatures required to detect
protein denaturation. The thermal transition at 33 °C (T1) may
have contributions from contaminating sebaceous lipids [64],
the solid-to-fluid transition of a subset of SC lipids [61] and the
transformation of an orthorhombic lipid packing to a hexagonal
arrangement [65], possibly occurring in different lipid domains
within the stratum corneum. Another low temperature transition
at approximately 55 °C (Tx) has been attributed to lipids
covalently bound to the corneocyte envelope proteins and FTIR
measurements indicated that this transition is due to the loss
of the crystalline, orthorhombic lattice structure of covalently
bound lipids [42,66–68]. ROC did not exhibit the T1 transition,
which may imply that these lipid domains are differently dis-
tributed during the thermal keratinocyte differentiation. It is not
clear why the Tx transition, tentatively attributed to protein-
bound ceramides of ROC (47 °C), occurs at a lower temperature
than in native skin (50 °C).
The lipid-associated transitions in human skin at 65–75 °C
(T2) are believed to be due to disordering of a lamellar lipid phase,
or more precisely, to a transition from a gel phase to a liquid
crystalline phase [6,64,65,68,69]. In the ROC, the T2 transition
occurred at a somewhat lower temperature (at 68 °C) compared to
human skin (at 74 °C). This phenomenonmay be partly due to theobserved differences in lipid composition of ROC, such as the
absence of ceramides NP and AP, small differences in fatty acid
chain lengths of ceramides and the over-expression of the fraction
of oleic acid in ω-hydroxyceramides, all of which can influence
lamellar and lateral lipid packing and be reflected in different
thermal profiles. The composition of ceramides in artificial
mixtures of stratum corneum lipids has been reported to influence
thermal behavior, e.g. the diversity of chain lengths of ceramides
and FFAs in the model mixture seems to mimic the phase beha-
vior of lipids in intact stratum corneum to a much greater extent
[70,71]. As compared to human skin, distinctly lower transition
temperatures (17 and 20 °C lower) have been found for two other
skin models [61,62]. The lipid arrangement of the RE-DED
model, which is believed to have a lipid composition and organi-
zation very similar to human skin, is transformed from a hexa-
gonal to liquid crystalline phase at a slightly lower temperature
(60–75 °C) than in human skin (65–90 °C) as determined by X-
ray diffraction [52]. Also the 12 nm lamellar long periodicity
phase (LPP) disappeared at a lower temperature (61–67 °C) than
the 13.4 nm LPP of human skin (67–75 °C) [31].
The transition at around 80 °C (T3) has been attributed to the
gel to liquid crystalline phase transformation of protein-bound
lipids in the cornified envelope [64,68,69]. In ROC, the T3
transition occurred at a slightly higher temperature (89 °C) than
in human skin (86 °C) (Fig. 5). This phenomenon has not been
previously reported in the literature, but it might cause some
structural differences in lipid–protein complexes. However, in
the ROC the enthalpy of this peak was significantly less,
indicative of a lower amount of covalently bound lipids than in
skin, in agreement with the TLC data.
We are interested in evaluating the ROC as a potential sub-
stitute for human skin in percutaneous absorption and skin irri-
tation studies, and therefore comparison ismade in the present and
previous experiments with human skin instead of rat skin. Thus,
the crucial issue is how successful theROCmodel is inmimicking
the behavior of human skin with respect to permeation and irri-
tation. Human and rat keratinocytes are different and they do not
produce similar permeation barriers. ROC is leakier than human
skin but it is significantly less permeable than rat skin [37,72]. The
thermal lipid phase transitions of ROCwere not identical to either
human or rat [67]. Ceramides NP and AP are produced in rat
keratinocytes but theywere absent in the ROC [73]. Therefore, we
would probably reach the same conclusion even if we used rat
skin as our comparison. The formation of the cultured stratum
corneum is largely governed by the keratinocyte expression pro-
file and differentiation process, and not simply by the cell origin.
REK is a continuous cell line and therefore ROC cultures are
easy to prepare, always available, and reproducible. The main
advantage of ROC is its well developed permeability barrier,
which closely resembles human skin [37]. This is important
with respect to solute permeation, permeation enhancement
effects, and chemical irritation [37–39]. The lipid matrix con-
stitutes the major barrier to the penetration of drugs and
chemicals. Therefore, the differences and similarities in lipid
composition and in lipid-associated thermal transitions demon-
strated in this study may explain the similar, but not identical
permeation barrier of ROC in comparison to human skin. Based
832 S. Pappinen et al. / Biochimica et Biophysica Acta 1778 (2008) 824–834on the observations in this and previous studies, the structure of
the stratum corneum in ROC seems to be less ordered and the
polar permeation pathway is more predominant than is the case
in human skin [39].
In conclusion, ceramides, free fatty acids and cholesterol,
which are the most important elements for the formation of the
highly ordered structure of stratum corneum lipid domains, were
all present in ROC in amounts similar to those found in human
skin. The most significant differences were the absence of two
ceramide classes, partial substitution of linoleate for oleate inω-
hydroxyceramides and the lower level of bound ceramides.
These variations could partly explain the different thermal be-
havior and somewhat higher permeability of ROC vs human
skin. In the future, modifications of the culture conditions, e.g.
supplementation with essential fatty acids, may bring the lipid
composition and structure of ROCmore close to those of human
skin. This knowledge of the differences and similarities in the
lipid matrix of ROC provides additional information to under-
stand the relevance of results in future studies with this model.
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